DJO Reports March 2019 Revenue of $37.2MM, +17.4% vs. March 2018

by Mike Evers on May 23, 2019

DJO posted March 2019 revenue of USD $37.2MM, +17.4% vs. March 2018.

Revenue for 1Q19 is for March only, as Colfax completed the acquisition of DJO on February 22, 2019
Growth was driven by sales of joint replacement products, while prevention and rehab (categorized in our “Other” segment) remain on track with improvement...

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	Mar-19	Mar-18	$ Chg	% Chg
Joint Reconstruction	$29.1	$24.5	$4.7	19.0%
Knees	$7.7	$6.4	$1.3	19.7%
Hips	$6.5	$5.5	$1.0	18.1%
Extremities	$14.9	$12.5	$2.4	19.1%
Other	$8.0	$7.2	$0.8	11.8%
Total	$37.2	$31.7	$5.5	17.4%

	Mar-19	Mar-18	$ Chg	% Chg
Joint Reconstruction	$29.1	$24.5	$4.7	19.0%
Knees	$7.7	$6.4	$1.3	19.7%
Hips	$6.5	$5.5	$1.0	18.1%
Extremities	$14.9	$12.5	$2.4	19.1%
Other	$8.0	$7.2	$0.8	11.8%
Total	$37.2	$31.7	$5.5	17.4%

DJO Reports March 2019 Revenue of $37.2MM, +17.4% vs. March 2018

Orthopedics’ Top Tier to Expand in 2024

Miach Orthopaedics Raises $20 Million in Series B Extension

10 Orthopedic Companies Close New Funding Rounds in 1Q24

Carlsmed Raises Series C to Support aprevo

U.S. Market Key to Unlocking Orthofix’s Trauma Business

Get the ORTHOWORLD Newsletter!

Contact Us